Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: A comparative study

Journal of Immunology

Volumn 163, Issue 8, 1999, Pages 4473-4480

  Fawaz, Lama M ^a,b   Sharif Askari, Ehsan ^a,c   Menezes, José ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOSURVEILLANCE; INFLUENZA VIRUS; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; REGULATORY MECHANISM; REOVIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENDAI VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

EID: 0032825232     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, et al. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965.
2. Anderson, D. M., L. Johnson, M. B. Glaccum, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, V. Valentine, M. Kirstein, D. N. Shapiro, and S. W. Morris. 1995. Chromosomal assignment and genomic structure of IL-15. Genomics 25:701.
3. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. H. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:2822.
4. Giri, J. G., D. M. Anderson, S. Kumaki, L. S. Park, K. H. Grabstein, and D. Cosman. 1995. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leukocyte Biol. 57:763.
5. Armitage, R. J., B. M. Macduff, J. Eisenman, R. Paxton, and K. H. Grabstein. 1995. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154:483.
6. Carson, W. E., J. G. Giri, M. J. Lindermann, M. L. Linett, M. Ahdieh, R. Paxton, D. M. Anderson, J. Eisenman, K. H. Grabstein, and M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395.
7. Giri, J., S. Kumaki, M. Ahdieh, D. J. Friend, A. Loomis, K. Shanebeck, R. DuBose, D. Casman, L. S. Park, and D. M. Anderson. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J. 14:3654.
8. Welsh, R. M. 1978. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J. Exp. Med. 148:163.
9. Bancroft, G. J. 1993. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 5:503.
10. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
11. Lanier, L. L., A. M. Le, J. H. Phillips, N. L. Warner, and G. F. Babcock. 1983. Subpopulation of human natural killer cells defined by expression of the leu 7 (HNK-1) and leu 11 (NK-15) antigens. J. Immunol. 131:1789.
12. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:567.
13. Tripp, C. S., S. F. Wolf, E. R., and Uranue. 1993. Interleukin 12 and tumor necrosis factor β are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
14. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infection in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731.
15. Ullum, H., P. C. Gotzsche, J. Victor, E. Diskmeiss, P. Skinhoj, and B. K. Pedersen. 1995. Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J. Exp. Med. 182:789.
16. Fleisher, G., S. Starr, N. Koven, H. Kamiya, S. D. Douglas and W. Henle. 1982. A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections. J. Pediatr. 100:727.
17. Flamand, L., I. Stefanescu, and J. Menezes. 1996. Human herpesvirus-6 enhances natural killer cytotoxicity via IL-15. J. Clin. Invest. 97:1373.
18. Atedzoe, B. N., A. Ahmad, and J. Menezes. 1997. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J. Immunol. 159:4966.
19. Gosselin, J., L. Flamand, M. D'Addario, J. Hiscott, and J. Menezes. 1992. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses: differential induction of interleukin 6 and tumor necrosis factor-α. J. Clin. Invest. 89:1849.
20. Mbiguino, A., and J. Menezes. 1991. Purification of human respiratory syncitial virus: superiority of sucrose gradient over percoll, renografin, and metrizamide gradients. J. Virol. Methods 31:161.
21. Khelifa, R., and J. Menezes. 1983. Sendai virus envelopes can mediate Epstein-Barr virus binding to and penetration into Epstein-Barr virus receptor-negative cells. J. Virol. 46:325.
22. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thyocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
23. Gosselin, J., L. Flamand, M. D'Addario, J. Hiscott, I. Stefanesco, D. V. Ablashi, R. C. Gallo, and J. Menezes. 1992. Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and confections on cytokine synthesis. J. Immunol. 149:181.
24. Bamford, R. N., A. P. Battiata, J. D. Burton, H. Sharma, and T. A. Waldmann. 1996. Interleukin (IL)-15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotropic virus typel region/ IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation. Proc. Natl. Acad. Sci. USA 93:2897.
25. Bamford, R. N., A. P. Battiata, and T. A. Waldmann. 1996. IL-15: the role of translational regulation in their expression. J. Leukocyte Biol. 59:476.
26. Herberman, R. B. 1982. NK Cells and Other Natural Effector Cells. Academic Press, New York.
27. Murphy, W. J., V. Kumar, and M. Bennett. 1987. Acute rejection of murine bone marrow allograft by natural killer cells and T cells. J. Exp. Med. 166:1499.
28. Bendelac, A., and D. T. Fearon. 1997. Innate Immunity: innate pathways that control acquired immunity. Curr. Opin. Immunol. 9:1.
29. Biron, C. A. 1997. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:24.
30. Lotzova, E., and R. B. Herberman, eds. 1986. Natural killer cells active against viral, bacterial, protozoan, and fungal infections. In Immunobiology of Natural Killer Cells, Vol. 2, CRC Press, Boca Raton, FL, p. 107.
31. Welsh, R. M. 1986. Regulation of virus infections by natural killer cells: a review. Nat. Immun. Cell. Growth. Regul. 5:169.
32. Borysiewicz, L. K., B. Rodgers, S. Morris, S. Graham, and J. G. P. Sissons. 1985. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells. J. Immunol. 134:2695.
33. Bukowski, J. F., J. F. Warner, G. Dennert, and R. M. Welsh. 1985. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. Med. 161:40.
34. Kawa-Ha, K., S. Ishihara, T. Ninomiya, K. Yumara-Yagi, J. Hara, F. Murayama, A. Tawa, and K. Hirai. 1989. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J. Clin. Invest. 84:51.
35. Fleisher, G., S. Starr, N. Koven, H. Kamiya, S. D. Douglas, and W. Henle. 1982. A non-X-linked syndrome with susceptibility to severe Epstein-Barr virus infections. J. Pediatr. 100:727.
36. Binder, D., J. Fehr, H. Hengartner, R. M. Zinkernagel. 1997. Virus-induced transient bone marrow aplasia: major role of interferon-α/β during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 185: 517.
37. Carson, W. E., M. E. Ross, R. A. Baiocchi, M. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96:2578.
38. + T cells or cytokines that signal through components of the IL-2R. J. Immunol. 157:2096.
39. Tyler, D., S. Stanley, C. Nastala, A. Austin, J. Bartlett, K. Stine, H. Lyerly, D. Bolognesi, and K. Weinhold. 1990. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. J. Immunol. 144:3375.
40. Buunsgaard, H., C. Pedersen, P. Skinhoj, and B. K. Pedersen. 1997. Clinical progression of HIV infection: role of NK cells. Scand. J. Immunol. 46:91.
41. +) subjects: enhancement with interleukin-2 (IL-2), IL-12, and IL-15. Clin. Immunol. Immunopathol. 82:163.
42. Loubeau, M., A. Ahmad, E. Toma, and J. Menezes. 1997. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15. J. Acquired Immune Defic. Syndr. Hum. Retroviral. 16:137.
43. Seder, R. A., K. H. Grabstein, J. A. Berzofsky, and J. F. McDyer. 1995. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15. J. Exp. Med. 182:1067.
44. Doherty, T. M., R. A. Seder, and A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:735.
45. Kacani, L., H. Stoiber, and M. P. Dierich. 1997. Role of IL-15 in HIV-1-associated hypergammaglobulinaemia. Clin. Exp. Immunol. 108:14.
46. Tagaya, Y., R. N. Bamford, A. P. De Filippis, and T. A. Waldmann. 1996, IL-15: a pleiotropic cylokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4:329.
47. Kozak, M. 1992. A consideration of alternative models for the initiation of translation in eukaryotes. Crit. Rev. Biochem. Mol. Biol. 27:385.
48. Vagner, S., M. Gensac, A. Maret, F. Bayard, F. Amalric, H. Prats, and A.-C. Prats. 1995. Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol. Cell. Biol. 15:35.
49. Meazza, R., A. Gaggero, F. Neglia, S. Basso, S. Sforzini, R. Pereno, B. Azzarone, and S. Ferrini. 1997. Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion, role of different signal peptides. Eur. J. Immunol. 27:1049.
50. Meazza, R., S. Verdiani, R. Biassoni, M. Coppolecchia, A. Gaggero, A. M. Orengo, M. P. Colombo, B. Azzarone, and S. Ferrini. 1996. Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene 12:2187.
51. Carson, W. E., T. A. Fehniger, S. Haldar, K. Eckhert, M. J. Lindermann, Chun-Failai, C. M. Croce, H. Baumann, and M. A. Caligiuri. 1997. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J. Clin. Invest. 99:937.